The use of OP-1 in femoral impaction grafting in a sheep model

被引:59
作者
McGee, MA
Findlay, DM
Howie, DW
Carbone, A
Ward, P
Stamenkov, R
Page, TT
Bruce, WJ
Wildenauer, CI
Toth, C
机构
[1] Univ Adelaide, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[2] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[3] Stryker Biotech, Hopkinton, MA USA
关键词
arthroplasty; allograft; femur; hip; BMP; impaction;
D O I
10.1016/j.orthres.2004.01.005
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The aim of this pilot study was to examine bone graft incorporation in femurs impacted with allograft bone alone (control group) or with allograft containing the bone morphogenetic protein OP-1 (BMP-7) (OP-1 group) in a sheep model of cemented hemiarthroplasty. Two sheep in each group were sacrificed at 6, 18 and 26 weeks. Successful bone graft incorporation was evident in both groups by six weeks but in the OP-1 group, there had been more extensive resorption of the graft. There was one case of excessive stem subsidence in the OP-1 group at six weeks. By 18 weeks, there was remodelling and trabeculation of the new bone in the OP-1 group, but this appeared less advanced in the control group. By 26 weeks, there was remodelling of bone in the graft bed. The results of this small study suggest that OP-1 promotes initial graft resorption, thus hastening bone graft incorporation and remodelling in femoral impaction grafting. The one case of stem subsidence may be associated with the early resorption seen in the OP-1 group and reinforces the need for further studies, examining dose response and using precise measures of stem movement, before this BNIP is used in femoral impaction grafting at revision hip arthroplasty. (C) 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 31 条
[1]
A controlled experimental model of revision implants Part II. Implementation with loaded titanium implants and bone graft [J].
Bechtold, JE ;
Mouzin, O ;
Kidder, L ;
Soballe, K .
ACTA ORTHOPAEDICA SCANDINAVICA, 2001, 72 (06) :650-656
[2]
The use of osteogenic protein-1 in reconstructive surgery of the hip [J].
Cook, SD ;
Barrack, RL ;
Shimmin, A ;
Morgan, D ;
Carvajal, JP .
JOURNAL OF ARTHROPLASTY, 2001, 16 (08) :88-94
[3]
The effect of recombinant human osteogenic protein-1 (bone morphogenetic protein-7) impregnation on allografts in a canine intercalary bone defect [J].
Cullinane, DM ;
Lietman, SA ;
Inoue, N ;
Deitz, LW ;
Chao, EYS .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (06) :1240-1245
[4]
EITEL F, 1981, ARCH ORTHOP TRAUM SU, V99, P59, DOI 10.1007/BF00400911
[5]
Field JR, 2001, VET COMP ORTHOPAED, V14, P32
[6]
Cemented femoral impaction bone grafting for severe osteolysis in revision hip arthroplasty - Good results at 4-year follow-up of 10 patients [J].
Flugsrud, GB ;
Ovre, S ;
Grogaard, B ;
Nordsletten, L .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2000, 120 (7-8) :386-389
[7]
Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect [J].
Geesink, RGT ;
Hoefnagels, NHM ;
Bulstra, SK .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1999, 81B (04) :710-718
[8]
IMPACTED CANCELLOUS ALLOGRAFTS AND CEMENT FOR REVISION TOTAL HIP-ARTHROPLASTY [J].
GIE, GA ;
LINDER, L ;
LING, RSM ;
SIMON, IP ;
SLOOFF, TJJH ;
TIMPERLEY, AJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1993, 75 (01) :14-21
[9]
GOEL VK, 1982, YALE J BIOL MED, V55, P113
[10]
Bone-graft substitutes: Facts, fictions, and applications [J].
Greenwald, AS ;
Boden, SD ;
Goldberg, VM ;
Khan, Y ;
Laurencin, CT ;
Rosier, RN .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2001, 83A :98-103